Vertis Biotechnologie AG

Company

    • Company type:
      • Manufacturer
    • Year founded:
    • 2000
    • Employees (at the site):
    • 4
    • Turnover range:
    • <5m EUR
    • Products/services:
    • VERTIS is a privately owned research service company with a focus on RNA sequencing and gene regulation analysis.
      Functional Genomics / Proteomics, Agrobiotechnology, Chip / Array Technology

    • Core competencies:
    • Founded 2000, vertis Biotechnologie AG is a research-orientated company in the field of functional genomics. vertis offers innovative tools for rapid identification of candidate genes employing straightforward gene enrichment strategies. These strategies translate into reduction of redundancy when looking at whole transcriptomes or removal of non target sequences allowing to focus on the genes of relevance. Thus, the technology platform of vertis significantly reduces time and costs for downstream gene analyses. The technology is coupled with increased sensitivity enabling the analysis of the transcriptome in as few as 100 cells. The application of the technology is examined in co-operations with research institutes and industrial partners. The aim is the development of DNA-based diagnostic kits for animal and human health care, for plant breeding and plant protection as well as the genomic-based discovery of new drugs and plant protective agents. The company participates in research projects and offers its platform technology as service.

    • Language skills:
    • English
    • Key Tech / section:
      • Biotechnology: Food and nutrition (incl. diagnostics)
      • Biotechnology: Molecular diagnostics for humans
    • Industries NACE:
      • 20.2: Manufacture of pesticides and other agrochemical products
      • 21.2: Manufacture of pharmaceutical preparations
      • 72.1: Research and experimental development on natural sciences and engineering
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Fritz Thümmler (Mr.)
      - Management